82/100 · Critical
59,130 FDA adverse event reports
NYSTATIN is manufactured by Padagis US LLC and is tracked in the FDA Adverse Event Reporting System (FAERS). There are 59,130 adverse event reports for NYSTATIN in the FDA database. Based on our AI analysis, NYSTATIN has a safety score of 82 out of 100.
This page focuses specifically on NYSTATIN as manufactured by Padagis US LLC, providing safety context within the manufacturer's broader drug portfolio. Different manufacturers of the same active ingredient may have different adverse event profiles due to variations in formulation, inactive ingredients, manufacturing processes, and patient populations.
The following adverse reactions have been most frequently reported for NYSTATIN manufactured by Padagis US LLC:
Out of 26,233 classified reports for NYSTATIN:
Explore other medications manufactured by Padagis US LLC in the FDA adverse event database:
The most commonly reported side effects of NYSTATIN include NAUSEA, FATIGUE, DIARRHOEA. These are based on 59,130 FDA adverse event reports.
NYSTATIN has a safety score of 82/100 based on AI analysis of FDA adverse event reports. Always discuss medication risks with your healthcare provider.